Dr. Reddy’s is a Mumbay and New York listed Indian generics company which strives to provide affordable and innovative medicines globally
OctoPlus is a Dutch listed company focused on the development of its proprietary drug formulation technologies, enhancing efficacy by applying liposomes and microspheres
Main transaction rationale for Dr. Reddy’s is to get access to the knowledge and capabilities of OctoPlus
Kempen & Co acted as financial adviser to Dr. Reddy’s